Morocco: Standing Firm
Valued by Fitch at a trifling USD 1.6 billion, the Moroccan pharma sector can be considered only a middling-size market by regional standards, and…
Tagged with Servier
Oncology in Morocco: Access Challenges & New Solutions
Morocco has made admirable progress in building a national oncology network in recent years, but the country’s cancer patients still face…
Morocco: Becoming a Pharma Manufacturing Hub for Africa
Multinational pharmaceutical companies are increasingly seeing Morocco as a top manufacturing destination for the African continent. Firms from…
Guillaume Recorbet – General Manager, Servier Morocco
Guillaume Recorbet, general manager of Servier in Morocco, explains Servier’s special status in the Moroccan pharma industry as a multinational…
Egis: Holding On To Hungarian Heritage
Established in Hungary in 1913, Egis is a traditional Central Eastern European pharmaceutical company with an international footprint across the…
Company Profile: Servier China, 40 Years of Commitment
2009 marks 40 years of China’s liberalization and opening up under then-Premier Deng Xiaoping. Servier China also bears the distinction of having…
France’s Mid-Cap Pharma Champions Look to Global Markets
With a feel-good factor sweeping French innovative pharma, the country’s iconic mid-cap biopharma standard-bearers are once more on the rise. These…
Thailand Pharma Country Managers: Where Are They Now?
PharmaBoardroom last reported on Thailand in 2015, meeting country managers from across the healthcare and life sciences value chain. Here, we chart…
New France Pharma Report June 2019 Out Now
The latest issue of Healthcare & Life Sciences Review France follows on from our March 2019 report and takes a closer look at the wider French…
Servier’s Olivier Laureau: Change Instigator
Not long ago, Laboratories Servier was considered a somewhat mysterious and opaque actor on the world pharmaceuticals stage. Privately owned, smaller…
5 Top European Mid-Cap CEOs To Know
Bringing together insights from the heads of some of Europe’s most prominent mid-cap pharma firms. The leaders of Ipsen, Genmab, Pierre Fabre,…
Olivier Laureau – President, Servier Group
Olivier Laureau, global president of Servier Group, outlines the impact of recent acquisitions, the significance of Servier’s recently-opened…
